Medication info

Bibozon Coolsan

Prescription medicationOralExpired
Ingredient · strength
Polyethylene Glycol 3350›50g / 1 packetAnhydrous Sodium Sulfate›3.75g / 1 packetSodium Chloride›1.3455g / 1 packetPotassium Chloride›0.5075g / 1 packetAscorbic Acid›2.35g / 1 packetSodium Ascorbate›2.95g / 1 packet
Manufacturer / importer
BIBOZON PHARMACEUTICAL Co., Ltd.
Appearance
A preparation: A white or slightly yellow powder in an aluminum foil pouch with a lemon scent. B preparation: White to slightly yellow crystals or crystalline powder in an aluminum foil pouch with no smell and a sour taste.
Packaging
1 box (A preparation 4 pouches + B preparation 4 pouches)
Approval status
Expired

MFDS item code 201803950 · Notified 2018.10.10

This product's status changed to Expired on 2023.10.10. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of bowel cleansing before colon examination
Who takes it
Adults
Adult dose
Adults aged 18 years and older should take the doses as described below, either in divided or undivided doses. [Preparation of the solution] Place 1 sachet of Product A and 1 sachet of Product B in a disposable container (500mL), dissolve in an appropriate amount of water, then add more water to the 500mL mark and shake well to prepare a homogeneous solution. Prepare the solution 4 times in total, 500mL each time. If needed, the solution may be refrigerated before drinking. The prepared solution should be stored in a refrigerator and used within 24 hours. [How to take] 1) Split-dose regimen: On the evening before the colonoscopy, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500ml of water. The next morning, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour, then drink an additional 500ml of water. This process must be completed at least 1 hour before the colonoscopy begins. 2) Non-split evening regimen: At around 6 p.m. on the evening before the colonoscopy, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour (one 250mL cup every 15 minutes). After 1.5 hours, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour, then drink an additional 1L of water.

Ingredients

Manufacturer
BIBOZON PHARMACEUTICAL Co., Ltd.

Efficacy & effects

Improvement of bowel cleansing before colon examination

View approved original text

This medication is used to thoroughly cleanse the colon as a preparation for undergoing colon X-ray or endoscopy.

How to take

Adult dose

Adults aged 18 years and older should take the doses as described below, either in divided or undivided doses. [Preparation of the solution] Place 1 sachet of Product A and 1 sachet of Product B in a disposable container (500mL), dissolve in an appropriate amount of water, then add more water to the 500mL mark and shake well to prepare a homogeneous solution. Prepare the solution 4 times in total, 500mL each time. If needed, the solution may be refrigerated before drinking. The prepared solution should be stored in a refrigerator and used within 24 hours. [How to take] 1) Split-dose regimen: On the evening before the colonoscopy, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500ml of water. The next morning, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour, then drink an additional 500ml of water. This process must be completed at least 1 hour before the colonoscopy begins. 2) Non-split evening regimen: At around 6 p.m. on the evening before the colonoscopy, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour (one 250mL cup every 15 minutes). After 1.5 hours, drink 1L of the prepared solution (prepare two 500mL portions) over 1 hour, then drink an additional 1L of water.

Precautions

This drug can rarely cause generalized tonic-clonic seizures even in patients without a seizure history, so caution is particularly needed in patients at risk of electrolyte imbalances. Patients taking diuretics or ACE inhibitors that can cause electrolyte imbalances or those suspected of hyponatremia should use this drug carefully. This medication should not be administered to patients with bowel obstruction, gastrointestinal obstruction, perforation, toxic colitis, or toxic megacolon, and it should be used cautiously in patients with severe ulcerative colitis. Patients with allergies to this drug or its components, those suspected of gastrointestinal obstruction or perforation, dehydrated patients, those with severe heart failure, or active cancer patients should not use this medication. Safety and efficacy have not been established in children under 18 years old, so it should not be administered. Patients with intestinal stenosis or severe constipation, elderly patients, frail patients, those with a vomiting reflex disorder, or patients with altered consciousness should use this drug with increased caution. This medication may cause various adverse reactions such as hunger, hypophosphatemia, hypokalemia, sleep disturbances, dizziness, headache, upper abdominal pain, abdominal pain, nausea, abdominal distension, anal discomfort, vomiting, dyspepsia, difficulty swallowing, lethargy, thirst, tremors, discomfort, decreased blood bicarbonate, decreased blood calcium, hypercalcemia, decreased or increased blood chloride, increased blood phosphate, liver function abnormalities, rash, runny nose, dermatitis, fever, chills, tremors, and renal function impairment. In particular, major side effects such as gastric mucosal damage, serious gastrointestinal bleeding, and acute pulmonary edema have been reported in elderly patients over 60 years old, requiring heightened caution. Before and during administration of this medication, the patient's bowel movement status should be verified to observe for proper bowel activity, and in cases of severe abdominal distension or pain, the rate of administration should be adjusted or discontinued, and a physician should be consulted. If symptoms of fluid and electrolyte imbalance appear, blood tests should be conducted to verify the status and appropriate treatment should be provided. It is important for patients with heart disease or at risk of electrolyte imbalances to check their condition with ECGs and blood tests before and after administration. This medication may cause diarrhea, so adequate hydration before and after administration is necessary. When used in conjunction with irritating laxatives, the risk of ulceration or ischemic colitis in the intestinal mucosa increases, so it is advisable not to use them together. This medication should be taken at least 1 hour after finishing a meal, and solid foods should be avoided during administration. Bowel movements typically begin about 1 hour after taking this medication, and abdominal distension may occur beforehand. The absorption of other oral medications may be hindered when this medication is taken, so it is advisable to space the administration times apart. Pregnant or breastfeeding women should only use this medication when the need for diagnosis is clearly established, as its safety has not been determined. In case of overdose, dehydration and electrolyte disturbances can become severe, and patients who have overdosed require immediate observation and treatment by medical personnel. This medication should be taken immediately after preparation, and any solution not used within 24 hours should be discarded, keeping it out of reach of children. Furthermore, transferring the solution to another container is not advisable for quality maintenance.

Side effects

Hunger, hypophosphatemia, hypokalemia, sleep disturbances, dizziness, headache, upper abdominal pain, abdominal pain, nausea, abdominal bloating, anal discomfort, vomiting, indigestion, difficulty swallowing, fatigue, thirst, trembling, discomfort, decrease in serum bicarbonate, decrease in serum calcium, hypercalcemia, decrease or increase in serum chloride, increase in serum phosphate, liver dysfunction, rash, urticaria, runny nose, dermatitis, edema, anaphylaxis-like reaction, upper gastrointestinal bleeding due to gastric mucosal damage, esophageal perforation, cardiac standstill, acute pulmonary edema, tachycardia, palpitations, hypertension, arrhythmia, atrial fibrillation, peripheral edema, syncope, dehydration, anaphylactic reaction, itching, lip swelling, tongue swelling, facial swelling, dyspnea, chest tightness, throat tightness, fever, chills, tremors, seizures, renal dysfunction, renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It should also be kept away from extreme heat or cold, ideally at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A preparation: A white or slightly yellow powder in an aluminum foil pouch with a lemon scent. B preparation: White to slightly yellow crystals or crystalline powder in an aluminum foil pouch with no smell and a sour taste.

Package unit

1 box (A preparation 4 pouches + B preparation 4 pouches)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.